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ABSTRACT 
Background: Integrin !3 (ITGB3) and Toll-like receptor 2 (TLR2) are candidate genes for asthma and 
sensitization to mold allergens. Integrin !3 forms a complex with TLR2, and this biological interaction is 
required for the response of monocytes to TLR2 agonists such as fungal glucan. Objective: To study whether 
genetic interaction between single nucleotide polymorphisms (SNPs) in genes encoding the TLR2-ITGB3 
complex enhances susceptibility to mold sensitization. Methods: Association analysis was conducted in 1243 
adults (524 with asthma) who participated in the follow-up of the Epidemiological Study on the Genetics and 
Environment of Asthma (EGEA). Allergic sensitization to mold allergens was determined by skin prick testing 
(SPT). Association of mold sensitization with 14 ITGB3 SNPs was tested under an additive genetic model. 
Interaction between ITGB3 SNPs and TLR2/+596, which was previously shown to be associated with asthma, 
was studied. Results: Positive SPT to mold was found in 115 subjects with asthma (22.0%), and in 61 subjects 
without asthma (8.5%). The ITGB3 rs2056131 A allele was associated with mold sensitization in subjects with 
asthma with an odds ratio and 95% confidence interval of 0.60 (0.43-0.83), P=0.001. Ten other ITGB3 SNPs 
were significantly associated with mold sensitization in TLR2/+596TT subjects with asthma (P=0.03 to 0.002), 
whereas much weaker associations were found in carriers of the TLR2/+596 C allele (P=0.60 to 0.04). 
Interaction between TLR2/+596 and these ITGB3 SNPs was statistically significant (P interaction=0.05 to 
0.001). 
Conclusion: TLR2/+596 genotype may influence the association between ITGB3 SNPs and mold sensitization 
in adults with asthma. 
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 Key Messages 
• TLR2/+596 genotype may influence the association between  ITGB3 SNPs and mold sensitization in adults 
with asthma. 
• Findings in this population study are consistent with a biological interaction between integrin !3 and TLR2 
in the innate immune response to fungal agents. 
 
Capsule summary 
This study sheds more light on the role of genetic variants in mold sensitization. Our results suggest that 
polymorphisms in ITGB3 and TLR2 interact to increase susceptibility to mold sensitization among subjects with 
asthma.  
 
Key words  
Alternaria; Aspergillus; allergy; asthma; Cladosporium; epidemiology; epistasis; genetics; innate immunity 
 
Abbreviations 
CI: Confidence interval 
EGEA: Epidemiological study on the Genetics and Environment of Asthma 
FDR: False discovery rate 
GEE: Generalized estimating equations 
ICS: Inhaled corticosteroids 
ITGB3: Integrin !3 
LD: Linkage disequilibrium 
OR: Odds ratio 
SNP: Single nucleotide polymorphism 
SPT: Skin prick test 
TLR2: Toll-like receptor 2 
 
INTRODUCTION 
Allergic sensitization to molds such as Alternaria and Cladosporium is a risk factor for asthma, asthma severity, 
and allergic rhinitis.
(1-3)
 The prevalence of mold sensitization depends strongly on geographic and climatic 
conditions,
(3, 4)
 and exposure to indoor mold allergens has been associated with mold allergy and asthma 
symptoms in children and adults.
(5-8)
 Besides the influence of the environment, heritable factors were shown to 
contribute to mold sensitization as well. Concordance for skin prick testing to a mixture of Alternaria allergens 
was significantly greater among identical twins than for non-identical twins,
(9)
 and maternal sensitization to 
Alternaria alternata significantly increased the risk of matched sensitization in their children.
(10)
 Only a small 
number of candidate gene studies investigated the role of specific genetic variants in mold sensitization.
(11-14)
 
Weiss et al.
(12)
 found that single nucleotide polymorphisms (SNPs) in the
 
integrin !3 gene (ITGB3), which is 
located on chromosome 17q21.32, were associated with asthma and sensitization to mold allergens in Hutterites, 
a founder population, and in three outbred replication populations, whereas other allergens showed no 
association. A candidate gene study and a study that used genome-wide genotyping to assess the reproducibility 
of previously published asthma genes also found associations between ITGB3 SNPs and asthma, but these 
studies did not investigate mold sensitization as an outcome.
(15, 16)
  
ITGB3 encodes the beta chain of the receptor for a wide array of ligands including vitronectin and fibrinogen. 
Integrin !3 and its ligands play a key role in cell adhesion, cell proliferation and differentiation, platelet 
activation, and various other biological processes.
(17)
 Vitronectin may participate in the remodelling process
 
during lung development or response to injury by downregulating the expression of "-smooth muscle actin and 
reducing the contractile ability of human lung fibroblasts.
(18)
 
Integrin !3 forms a complex with Toll-like receptor 2 (TLR2), and vitronectin and integrin !3 are required for 
the response of monocytes to bacterial lipopeptide and other TLR2 agonists such as fungal glucan.
(19)
 We 
therefore hypothesized that variants in genes encoding the TLR2-ITGB3 complex may play a role in 
susceptibility to asthma and mold sensitization. 
The present study is the first epidemiological study to address a gene-gene interaction between ITGB3 and 
TLR2. In adults from the French Epidemiological study on the Genetics and Environment of Asthma (EGEA), 
the TLR2/+596 (rs3804099) C allele was associated with asthma in both case-control and family-based 
analyses.
(20)
 We aimed to study whether TLR2/+596 genotype modified associations between ITGB3 SNPs and 
asthma and sensitization to mold allergens. In addition, we aimed to confirm associations between ITGB3 SNPs 
and asthma and mold sensitization. 
  
  Page 3 of 11  
METHODS 
Population 
The present analysis uses data from the 12-year follow-up of the EGEA survey. The design and protocol of 
EGEA, a family study and a case-control study of asthma, have been reported in detail elsewhere.
(21, 22)
 Briefly, 
2047 subjects were enrolled at baseline (1991-1995): 388 asthma patients (aged 7 to 70 years) from six chest 
clinics in five French cities, their 1244 first degree relatives, and 415 population-based controls. At follow-up 
(2003-2007), 92.2% of the alive cohort returned a self-completed questionnaire, and 77.1% completed a detailed 
questionnaire.
(23)
 At the follow-up survey, all subjects were adults. For the present cross-sectional analysis, we 
used 1243 subjects (62.8% of the alive cohort) with complete data on asthma, mold sensitization, and 
genotyping (Figure E1 in the online supplement shows a flowchart). The 1243 subjects with complete data were 
slightly older, had more often studied at university level, and reported rhinitis more often than the 300 subjects 
who were excluded due to missing genotype or phenotype (mold sensitization) data (Supplementary Table E1). 
All participants gave written informed consent. 
 
Health outcomes and exposure variables 
Inclusion criteria used to define asthma in probands were based on self-reported answers to the four questions 
“Have you ever had attacks of breathlessness at rest with wheezing?”, “Have you ever had asthma attacks?”, 
“Was this diagnosis confirmed by a physician?”, and “Have you had an asthma attack in the last 12 months?”, or 
a positive response to at least two questions and a positive review of their medical record.
(21)
 Asthma in relatives 
of probands was defined as a positive answer to at least one of the first two questions.
(21)
 
Atopy was defined by the presence of a positive skin prick test (SPT) (mean wheal diameter # 3 mm) to at least 
one of 11 aeroallergens (Aspergillus, Cladosporium herbarum, Alternaria tenuis (=alternata), cat, 
Dermatophagoides pteronyssinus, Blattella germanica, olive, birch, Parietaria judaica, timothy grass, and 
ragweed pollen) using extracts made by Stallergènes (Antony, France). Mold sensitization was defined as a 
positive SPT to at least one of the 3 mold allergens. Mold species tested in EGEA were the same as in the study 
by Weiss et al.
(12)
  
Environmental exposure to molds was assessed by questionnaire using items from the European Community 
Respiratory Health Survey.
(6)
 A small lake near Montpellier was assumed to be a source of molds,
(24)
 we 
therefore investigated recruitment in Montpellier as an environmental determinant of mold sensitization. 
 
Genotyping 
Fourteen SNPs in ITGB3 (located at chromosome 17q21.32) with a minor allele frequency >5% were selected 
using a tagging approach. All SNPs were in Hardy-Weinberg equilibrium (P>0.01). Online Figure E2 shows 
linkage disequilibrium (LD) between SNPs. Genotyping was performed using Taqman Probes (Applied 
Biosystems, Foster City, CA) on an ABI7900HT Sequence Detection System at the Centre National de 
Génotypage (CNG, Evry, France). 
 
Data analysis 
Analyses using mold sensitization as an outcome were conducted in subjects with and without asthma 
separately, because mold sensitization is strongly associated with asthma, and subjects were recruited through 
patients with asthma. Determinants of mold sensitization were first explored by using univariate analyses (Chi-
square test or t-test). All further analyses were done by generalized estimating equations (GEE model) to 
account for dependence among subjects sharing the same household. Odds ratios (ORs) and 95% confidence 
intervals (CIs) were adjusted for age and sex, unless stated otherwise. In the lack of evidence for a recessive or 
dominant genetic model, the effect of ITGB3 SNPs on health outcomes was tested under an additive genetic 
model with the minor allele as risk allele.
(12,15,16)
 To test whether association between ITGB3 SNPs and health 
outcomes were modified by TLR2/+596 (rs3804099) genotype (TT or CC+CT) we introduced a multiplicative 
gene-gene interaction term in the GEE model and used a generalized score test which follows a chi-square 
distribution with 1 degree of freedom. False Discovery Rate (FDR) adjusted P-values were calculated to take 
multiple comparisons (n=14 SNPs) into account.
(25)
 
 
RESULTS 
Association of mold sensitization and asthma 
The present study comprised 524 subjects with asthma and 719 subjects without asthma. Mold sensitization was 
significantly more prevalent among subjects with asthma (n=115, 22.0%) than in subjects without asthma 
(n=61, 8.5%), with an adjusted OR (95%CI) of 2.80 (2.03-3.87). Exclusive mold sensitization was rare: only 13 
(2.5%) subjects with asthma and 16 (2.2%) subjects without asthma were sensitized to mold without being 
sensitized to any of the other common allergens. Alternaria, Cladosporium, and Aspergillus sensitization were 
present in 71 (13.5%), 39 (7.4%), and 29 (5.5%) subjects with asthma and 27 (3.8%), 25 (3.5%), and 22 (3.1%) 
subjects without asthma, respectively. Atopy (sensitization to any of the 11 allergens tested) was found in 414 
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(79.0%) subjects with asthma, and in 277 (38.5%) subjects without asthma. Subjects with asthma who were 
sensitized to mold had more often used corticosteroids in the past year, and tended to have a lower age at the 
onset of asthma than those who were not sensitized to mold (52.6% vs. 40.1% and 13.1 y vs. 16.1 y, 
respectively; Table 1). 
 
Determinants of mold sensitization 
Table 1 shows determinants of mold sensitization in subjects with and without asthma (univariate analysis). 
Subjects with asthma who were sensitized to mold were younger, and more likely to be recruited in Montpellier 
than in the other centers. Among subjects without asthma, those sensitized to mold allergen were more often 
female, and recruited in Montpellier than those who were not sensitized to mold. Smoking habits and the 
presence of molds or water damage in the home were not associated with mold sensitization. Multiple regression 
models that included age, sex, and recruitment in Montpellier showed similar results as the univariate analyses. 
Recruitment in Montpellier was more strongly associated with sensitization to Alternaria alternata than to other 
mold allergens (OR 7.99 (3.24-19.66) and OR 4.18 (1.81-9.69), respectively). 
 
Association of ITGB3 SNPs, mold sensitization, asthma and atopy
 
The ITGB3 rs2056131 A allele was associated with a lower prevalence of mold sensitization in subjects with 
asthma, with a frequency of 26% in mold sensitized subjects and 37% in subjects not sensitized to mold (OR 
0.60 (0.43-0.83); Table 2). The P-value (0.001) was still statistically significant after correction for multiple 
testing. The same direction of association was shown for subjects without asthma, but the association was not 
significant (P=0.16). Among subjects with asthma, similar associations with ITGB3 rs2056131 were found for 
each of the mold allergens: Cladosporium OR 0.49 (0.27-0.89), Aspergillus OR 0.47 (0.25-0.86), and Alternaria 
OR 0.70 (0.49-1.01). Excluding subjects from Montpellier, or adjusting for recruitment in Montpellier did not 
change results (OR 0.56 (0.39-0.81) and OR 0.57 (0.41-0.81), respectively). Correction for other potential 
confounders (educational level, use of corticosteroids, and smoking habits) did also not change results (OR 0.58 
(0.37-0.90)). Analysis restricted to 414 atopic subjects also resulted in a similar OR (0.62 (0.45-0.86)). ITGB3 
SNPs were not associated with asthma or atopy (P>0.05; Supplementary Table E2 and E3).  
 
Gene-gene interaction between ITGB3 and TLR2 
TLR2/+596 CC+CT was associated with asthma at the follow-up survey (OR 1.75 (1.36-2.26); P<0.0001), 
confirming the earlier reported association among adults at baseline.
(20)
 TLR2/+596 CC+CT was not associated 
with mold sensitization in subjects with asthma (OR 1.13 (0.70-1.83) or subjects without asthma (OR 1.25 
(0.70-2.24)). Among subjects with asthma, the associations between ITGB3 SNPs and mold sensitization 
analyzed according to TLR2/+596 genotype showed statistically significant associations between 11 ITGB3 
SNPs and mold sensitization in TLR2/+596TT subjects (P=0.03 to 0.002), whereas much weaker or no 
associations were found in carriers of the TLR2/+596 C allele (P=0.60 to 0.04). Gene-gene interaction was 
statistically significant for 10 ITGB3 SNPs (P interaction=0.05 to 0.001), and remained significant for 7 SNPs 
after adjusting for multiple comparisons (Table 3). Excluding subjects from Montpellier or adjusting for 
recruitment did not change these findings. The LD pattern (online Figure E2) shows that the SNPs involved in 
the interaction belong to different haplotype blocks. When a forward stepwise regression was applied in 
TLR2/+596TT subjects, two ITGB3 SNPs that were not in LD (r
2
=0.00) entered the model with P<0.05, 
suggesting that they were both independently associated with mold sensitization (rs15908 (V381V) and 
rs11079772 (3’UTR)). Both gene-gene interaction terms were statistically significant in a multiple regression 
model (rs15908 x TLR2/+596, p=0.02; rs11079772 x TLR2/+596, p=0.006; Figure 1). Among subjects without 
asthma, association between ITGB3 SNPs and mold sensitization was not modified by TLR2/+596 (P 
interaction>0.05; Supplementary Table E4). Furthermore, TLR2/+596 did also not modify associations between 
ITGB3 SNPs and asthma (P interaction>0.05; Supplementary Table E5) or atopy (P interaction>0.05; data not 
shown). 
 
 
DISCUSSION 
In the present study, we found significant associations between ITGB3 SNPs and mold sensitization among 
adults with asthma, which were confined to carriers of the TLR2/+596TT genotype. Our findings suggest a 
gene-gene interaction between ITGB3 and TLR2/+596 in mold allergen sensitization. These results are 
consistent with the biological interaction between integrin !3 and TLR2 that was recently demonstrated, 
suggesting an important role of the integrin !3-TLR2 complex in the innate immune response to fungal 
agents.
(19)
 
Testing associations of multiple ITGB3 SNPs and three phenotypes may have resulted in chance findings, which 
is a limitation of our study. However, our finding of epistasis between ITGB3 and TLR2 was still significant for 
seven ITGB3 SNPs after correction for multiple testing. Another limitation is that skin tests were performed 
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with mold extracts which were not fully standardized and some subjects with mold allergy may have been 
missed. The allergen extracts were however of similar quality as those tested by Weiss et al.
(12)
 The 
biochemistry of mold allergens is still poorly understood, and the concordance between skin prick test (SPT) 
and specific serum IgE results for individual molds is much lower than for non-fungal allergens.
(26)
  
Interestingly, TLR2/+596 T/C did not modify associations between ITGB3 SNPs and asthma or atopy, 
suggesting that the gene-gene interaction between TLR2 and ITGB3 may be specific for the response to molds. 
Weiss et al. also found associations between ITGB3 SNPs and allergic sensitization to molds, but not to other 
common allergens.
(12)
 It is not clear whether our results concern one or more specific mold species, or rather 
mold allergens in general. We found similar risk estimates for the association between ITGB3 rs2056131 and 
each of the three molds studied, but there was insufficient statistical power to study the interaction between 
TLR2 and ITGB3 for allergic sensitization to each of the three individual mold species.  
Multiple regression analysis showed that at least two ITGB3 SNPs, rs15908 (V381V) and rs11079772, were 
independently involved in the interaction with TLR2. Rs2015729, a noncoding ITGB3 SNP in high LD with 
rs15908, was previously associated with decreased ITGB3 expression levels, which may provide a potential 
mechanism by which noncoding ITGB3 variants have a functional effect.
(27)
 Another functional ITGB3 SNP 
(rs5918, Leu33Pro) has been associated with various effects, including enhanced thrombin formation,
(28)
 
coronary heart disease,
(29)
 and cancer susceptibility.
(30)
 ITGB3 Leu33Pro was not genotyped in the present study, 
but it was in LD (r
2
=0.76) with rs10514919, a SNP that showed a significant interaction with TLR2 (P=0.05). 
Besides main effects of ITGB3 variants on various clinical outcomes, three studies have presented evidence for 
epistasis between ITGB3 and the serotonin transporter gene SLC6A4 in autism susceptibility 
(27, 31, 32)
 and in 
serotonin levels.
(31)
 Altogether, these findings suggest that multiple functional ITGB3 SNPs may have different 
pleiotropic effects, possibly in interaction with other genes. 
We can only speculate on the mechanism by which the effect of ITGB3 SNPs on mold sensitization is modified 
by TLR2/+596. A recent study has shown that peripheral blood leukocytes of TLR2/+596 TT subjects produce 
significantly less cytokines in response to bacterial lipoprotein stimulation than those of TLR2/+596 CT and CC 
subjects.
(33)
 Moreover, TLR2/+596 TT was the only TLR2 variant associated with a lower sepsis morbidity 
rate.
(33)
 The TLR2/+596 C allele was associated with asthma in both case-control and family-based
 
analyses 
among EGEA adults, which is consistent with a functional role of TLR2/+596.
(20)
 However, the exact functional 
significance of TLR2/+596 is so far unknown. A possible explanation could be a different expression of TLR2 
on
 
the surface of innate immune cells among subjects carrying the TT genotype compared with subjects carrying 
the C allele. In subjects with certain functional ITGB3 SNPs, a modified TLR2 expression may potentially result 
in a decreased function of the ITGB3-TLR2 complex. Finally, it can be hypothesized that this altered function 
could lead to a less effective response to fungal agents resulting in an increased risk of mold sensitization.  
We did not replicate associations between ITGB3 variants and asthma.
(12, 15)
 In a recent study that used genome-
wide genotyping to assess reproducibility of SNPs in 39 previously reported asthma genes, only 10 SNPs in 6 
genes were significantly associated with childhood asthma, including one SNP in ITGB3, which was not 
included in the present study.
(15)
 Our study had sufficient statistical power (80%) to detect a relative risk (RR) 
between 1.32 and 1.40 for the association between ITGB3 SNPs and asthma, and a RR between 1.66 and 1.82 
for the association between ITGB3 SNPs and mold sensitization in asthmatics, depending on disease allele 
frequency (varying between 0.19 and 0.40), and using the conservative Bonferroni correction for multiple 
comparisons. These RR seem reasonable and suggest that the lack of association cannot be attributed to a lack of 
power in our study. Replicating asthma susceptibility genes is a major challenge, and failure to replicate may be 
caused by heterogeneity between studies. Replicating interactions appears even more complicated.
(34,35)
  
Findings of our epidemiological study were analogous to a previously reported biological interaction between 
integrin !3 and TLR2.
(19) 
In addition, we have attempted to replicate our findings in the population of adult 
Hutterites.
(12)
 However, in that population only 93 subjects carried TLR2/+596 TT, and only 42 subjects were 
sensitized to mold (Dr. C. Ober, personal communication). Thus, there was no sufficient power to study 
interactions in this population. Moreover, Hutterites in general have a mild form of asthma, with corticosteroid 
use being quite rare. Other populations that were considered had not assessed sensitization to (the same) mold 
allergens. Variation between studies in asthma definition, age at onset, ethnicity, and other characteristics of the 
study population may reduce reproducibility. Furthermore, the influence of environmental exposures may also 
obscure genetic associations. For example, consistent associations between CD14/-260 and asthma or allergic 
sensitization were observed only after taking environmental endotoxin levels into account.
(36)
 The present study 
would have benefited from measured fungal allergen and/or glucan levels in settled house dust. Due to the lack 
of objectively assessed environmental exposure, we cannot exclude the possibility that gene-environment 
interactions play an additional role in association of ITGB3 and asthma or mold sensitization. In the present 
study we found an expected higher prevalence of mold sensitization in subjects recruited in Montpellier, where 
environmental exposure to mold was elevated.
(24)
 However, excluding subjects from Montpellier, or adjusting 
for recruitment did not affect the results. In US homes, Alternaria antigen concentrations were higher in homes 
where either residents or field workers observed signs of mold or dampness,
(37)
 and exposure to Alternaria was 
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associated with asthma symptoms.
(8) 
We also investigated water damage and visible mold in the home as self-
reported mold exposures, but these were not associated with mold sensitization. 
We did not study severity of asthma as another phenotype, although mold sensitization is known to be 
associated with a more severe asthma phenotype.
(1)
 In adult asthma patients from EGEA who did not use 
inhaled corticosteroids (ICS), mold sensitization was significantly associated with an increased risk for 
uncontrolled asthma (OR, 95% CI of 3.15, 1.02-9.78), but not for partly controlled asthma.
(23)
 However, mold 
sensitization was not associated with an increased risk for uncontrolled asthma in ICS users.
(23)
 The number of 
subjects did not allow further stratification for ICS use, or stratification for multiple levels of asthma control or 
asthma severity, and therefore we decided not to study associations between uncontrolled asthma or asthma 
severity and ITGB3 genotype in the present study. 
In conclusion, our epidemiological study suggests that genetic variants in ITGB3 and TLR2 interact to increase 
susceptibility to mold sensitization among subjects with asthma. Following an experimental study that 
demonstrated the essential role of integrin !3 in TLR2 signaling,
(19)
 our population study was the first to show 
this specific gene-gene interaction, which may influence the demonstrated biological interactions. Future studies 
need to replicate these findings, and functional experiments are needed to assess the mechanism by which 
ITGB3 and TLR2 SNPs influence susceptibility to mold sensitization. 
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Figure 1. Association of two ITGB3 SNPs (rs15908 A/C and rs11079772 A/C) with mold sensitization in a 
multiple regression analysis, stratified by TLR2/+596 genotype. ITGB3 SNPs were tested under an additive 
model among subjects with asthma. 
*
P value for interaction <0.05; 
**
P value for interaction <0.01. 
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Table 1. Asthma characteristics and determinants of mold sensitization in 524 adults with asthma and 719 adults without asthma. 
  Subjects with asthma  Subjects without asthma 
 
Data 
available 
for n 
subjects 
Mold SPT- Mold SPT+ P 
Data 
available 
for n 
subjects 
Mold SPT- Mold SPT+ P 
N 524 409 115  719 658 61  
Sex, n (%) men 524 212 (51.8) 65 (56.5) 0.37 719 312 (47.4) 20 (32.8) 0.03 
Age (y), mean ± sd 524 39.9 ± 16.8 36.3 ± 16.5 0.04 719 46.5 ± 16.3 43.4 ± 16.2 0.16 
Status at inclusion  524   0.06 719   0.57 
 Probands, n (%)  188 (46.0) 68 (59.1)   0 (0) 0 (0)  
 Relatives, n (%)  182 (44.5) 39 (33.9)   383 (58.2) 39 (63.9)  
 Spouses, n (%)  4 (1.0) 2 (1.7)   67 (10.2) 4 (6.6)  
 Controls, n (%)  35 (8.6) 6 (5.2)   208 (31.6) 18 (29.5)  
Recruited in Montpellier, n 
(%) 
524 19 (4.7) 18 (15.7) <0.0001 719 33 (5.0) 10 (16.4) 0.0003 
Smoking habits 519   0.70 711   0.45 
 Never, n (%)  204 (50.4) 58 (50.9)   339 (52.1) 32 (52.5)  
 Former, n (%)  106 (26.2) 26 (22.8)   166 (25.5) 19 (31.2)  
 Current, n (%)  95 (23.5) 30 (26.3)   146 (22.4) 10 (16.4)  
Education at university level, 
n (%) 
518 197 (48.8) 63 (55.3) 0.22 710 304 (46.7) 39 (66.1) 0.004 
Living in a rural commune 
before 16y, n (%) 
511 156 (39.0) 39 (35.1) 0.46 696 238 (37.3) 15 (26.3) 0.10 
Water damage last year, n (%) 429 38 (11.3) 12 (12.9) 0.67 590 59 (11.0) 9 (17.7) 0.15 
Mold in any surface inside the 
home last year, n (%) 
457 72 (20.1) 17 (17.4) 0.55 619 100 (17.6) 9 (17.3) 0.95 
Asthma onset (y), mean ± sd 492 16.1 ± 15.7 13.1 ± 14.2 0.07 -- -- -- -- 
FEV1 % predicted, mean ± sd 523 92.5 ± 17.4 91.5 ± 18.8 0.60 -- -- -- -- 
Inhaled corticosteroids in the 
past 12 months, n (%) 
520 163 (40.1) 60 (52.6) 0.02 -- -- -- -- 
Active asthma
*
, n (%) 522 275 (67.6) 87 (75.6) 0.10     
*
Active asthma: asthma attack or asthma treatment in the past 12 months 
-- Data only shown for subjects with asthma 
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Table 2. Association of ITGB3 SNPs with mold sensitization under an additive model in 524 adults with asthma and 719 adults without asthma. 
     Subjects with asthma Subjects without asthma 
ITGB3 SNP Position Region Alleles
†
 MAF OR (95% CI) OR (95% CI) 
rs2317385 42684681 5’UTR G/A  0.19 1.21 (0.83-1.77) 1.14 (0.74-1.76) 
rs2056131 42688742 intron 1 G/A  0.33 0.60 (0.43-0.83)* 0.75 (0.51-1.12) 
rs4525555 42692948 intron 1 C/T  0.33 1.09 (0.80-1.48) 1.05 (0.72-1.53) 
rs3892084 42695420 intron 1 G/A  0.19 1.04 (0.72-1.49) 0.91 (0.57-1.46) 
rs10514919 42697128 intron 1 G/T  0.26 1.07 (0.76-1.51) 1.12 (0.73-1.72) 
rs8074094 42703020 intron 1 T/C  0.28 1.10 (0.79-1.53) 1.16 (0.77-1.73) 
rs3851806 42705918 intron 1 G/C  0.18 1.05 (0.72-1.53) 0.92 (0.56-1.50) 
rs2015729 42709492 intron 2 G/A  0.40 1.17 (0.87-1.58) 1.04 (0.73-1.48) 
rs2292699 42717294 intron 4 C/T  0.38 1.13 (0.83-1.53) 1.02 (0.71-1.47) 
rs15908 42723336 exon 9 V381V A/C  0.38 1.12 (0.83-1.52) 1.03 (0.71-1.50) 
rs2292863 42724129 intron 9 C/G  0.30 1.07 (0.77-1.49) 1.10 (0.74-1.62) 
rs3809863 42740011 intron 14 C/T  0.47 1.03 (0.77-1.39) 1.16 (0.85-1.59) 
rs11650072 42748664 3’UTR C/T  0.33 0.91 (0.66-1.25) 0.95 (0.67-1.35) 
rs11079772 42748738 3’UTR A/C  0.29 0.93 (0.67-1.29) 1.01 (0.69-1.47) 
*
FDR-corrected P<0.05; 
†
Major/Minor allele; MAF, minor allele frequency. 
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Table 3. Association of ITGB3 SNPs with mold sensitization under an additive model in adults with asthma, according to TLR2/+596 genotype. 
  
Carriers of 
TLR2/+596 TT (n=126) 
 
 
Carriers of 
TLR2/+596 CT or CC (n=362) 
 
ITGB3 SNP Alleles
†
 
Minor allele in 
mold SPT- 
subjects, n (%) 
Minor allele in 
mold SPT+ 
subjects, n (%) 
OR (95% CI) 
 
 
 
Minor allele in 
mold SPT- 
subjects, n (%) 
Minor allele in 
mold SPT+ 
subjects, n (%) 
OR (95% CI) P interaction 
rs2317385 G/A  37 (19)  11 (21) 1.19 (0.58-2.43)  101 (18) 34 (21) 1.24 (0.79-1.97) 0.91 
rs2056131 G/A  82 (41)  10 (19) 0.36 (0.18-0.72)  202 (36) 46 (29) 0.70 (0.47-1.03) 0.09 
rs4525555 C/T  54 (27)  23 (44) 1.94 (1.04-3.63)  185 (33) 47 (30) 0.89 (0.61-1.30) 0.04 
rs3892084 G/A  32 (16)  10 (19) 1.17 (0.54-2.55)  111 (20) 31 (19) 1.01 (0.65-1.55) 0.75 
rs10514919 G/T  44 (22)  19 (37) 1.89 (1.05-3.40)  145 (26) 36 (23) 0.83 (0.52-1.33) 0.05 
rs8074094 T/C  47 (24)  21 (40) 2.08 (1.16-3.73)  158 (28) 40 (25) 0.85 (0.55-1.32) 0.02* 
rs3851806 G/C  33 (17)  11 (21) 1.29 (0.63-2.62)  105 (19) 30 (19) 0.99 (0.63-1.56) 0.55 
rs2015729 G/A  66 (33)  30 (58) 2.79 (1.46-5.33)  231 (41) 61 (38) 0.91 (0.63-1.31) 0.003* 
rs2292699 C/T  62 (31)  28 (54) 2.43 (1.28-4.62)  218 (39) 57 (36) 0.90 (0.62-1.31) 0.009* 
rs15908 A/C  62 (31)  26 (54) 2.42 (1.24-4.70)  219 (39) 57 (36) 0.89 (0.61-1.29) 0.01* 
rs2292863 C/G  53 (27)  22 (42) 1.85 (1.03-3.33)  175 (31) 44 (28) 0.83 (0.54-1.27) 0.04 
rs3809863 C/T  103 (52)  15 (29) 0.37 (0.18-0.77)  252 (45) 86 (54) 1.38 (0.96-1.99) 0.001* 
rs11650072 C/T  61 (31)  27 (52) 2.38 (1.29-4.38)  201 (36) 42 (27) 0.65 (0.43-0.99) 0.001* 
rs11079772 A/C  53 (27)  22 (42) 1.89 (1.06-3.34)  174 (31) 39 (24) 0.72 (0.47-1.11) 0.01* 
*
FDR-corrected P<0.05.
 †
Major/Minor allele 
